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* * * Experimental lung colonization
assay. 2 x 105 F3II, F3II TP and F3II
NM cells were injected in the
lateral tail vein of mice. 21 days
later, mice were sacrifice. The
number of lung nodules per
animal is represented on the
graph. Data are expressed as
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Tumor progression. 2x105 F3II, F3II TP and
F3II NM were inoculated in the subcutis
of BALB/c mice. (A) The presence of
palpable tumor was registered.*p˂0,05
Logrank test. (B) y (C) Tumors were
measured thrice a week with caliper and
tumor volume was calculated. Mice were
sacrificed when the tumor volume was
2000 mm3. Statistical analysis were
conducted on tumor growth rates
calculated from day 10 onwards.
**p˂0,01. ***p˂0,001 ANOVA post test
Tukey´s multiple comparison test. Tumor
weight **p˂0,01 Kruskal-Wallis test. (D)





















Clonogenic capacity. 250 F3II, F3II TP and F3II NM cells were seeded in 12-wells
plate with DMEM 5% SFB. 7 days later, CFU(colony-forming unit) were fixed and
stained with methanol – crystal violet solution and counted in triplicates.
Representative microphotographs of the different cell lines on the colony
formation assay are shown at top of each bar (40X). Results are representative of
three independent experiments. **p˂0,01. ***p˂0,001. Kruskal-Wallis´ test.
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Cell adhesion capacity. 4,5 x104 cells F3II, F3II TP and F3II NM cells were seeded in a 96-well plates and
incubated for 3 different times (30, 60 and 90 minutes). After washing, adherent cells were fixed and stained
with crystal violet – methanol solution, solubilized in ethanol-acetic solution (3:1) and the absorbance was
measured at 570 nm. Data represent the means SD± of one representative experiment of at least three
independent experiments. **p˂0,01. ***p˂0,001 ANOVA post test Tukey´s multiple comparison test.
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INTRODUCTION
Breast cancer is the first cause of death from female
cancer. The recurrence of the disease originated at
the level of secondary organs, or metastasis, is
responsible for 90% of deaths from cancer. The
factors that endow these cells with metastatic
functions are largely unknown. One of the
limitations in the study of tumor cells with
aggressive phenotypes is that cell lines maintained in
culture lose this ability to invade and colonize
tissues. On the other hand, it has been shown that
reinjection of cells in animals can lead to their
enrichment with aggressive phenotypes. The aim of
this work was the isolation and characterization of
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Cell doubling time. 1,5 x104 F3II, F3II TP and F3II NM cells were seeded in 12-wells
plate. After incubation with DMEM 5% SFB for 24, 48, 72 and 96 h, each plate was
stained and fixed with crystal violet - methanol, resuspended in ethanol:acetic
solution (3:1) and measured at 570 nm. A growth curve given as 100% measured
at 24 h for each treatment was built. Statistical analysis was performed by
comparing the non-linear adjustment curves through its parameters.
Isolation of F3II TP and F3II NM. 2 x 105
F3II cells were inoculated in the subcutis
of BALB/c mice. When the tumor reached
2000 mm3, mice were sacrificed and a
fragment of 2 mm3 of tumor was
transplanted by surgery into another
mouse. This process was repeated twice.
After that, a primary cell culture was done
and the F3II TP cell line was established in
vitro. Meanwhile, other mouse was
sacrificed and a pulmonary nodule of its
was taken and transplanted by surgery
into another mouse. When the tumor
reached 2000 mm3, mice were sacrificed
and a fragment of 2 mm3 of tumor was
transplanted by surgery into another
mouse. This process was repeated twice.
After that, a primary cell culture was done
and the F3II NM cell line was established
in vitro.
Epithelial mesenchymal transition. The first stage of metastatic process
involves epithelial cells losing their polarity and detaching from the
basement membrane. The next step involves epithelial mesenchymal
transition (EMT) and an angiogenic switch, faciliting the malignant phase of
tumor growth. This EMT enable cancer cells to enter the circulation and exit
the blood stream at a remote site, where they may grow and form micro and
macro metastases, which may involve METs (Mesenchymal epithelial
transition) and thus a reversion to an epithelial phenotype. Some of the
epithelial and mesenchymal cell markers used by EMT researchers are listed.
The ones that are highlighted were used to identify this markers in F3II, F3II
TP and F3II NM cell lines. (Modified of Kalluri, et al. 2009)
Epithelial and mesenchymal markers expression in F3II, F3II TP and F3II NM cell
lines. The expression of the epithelial markers, E- cadherin and Pan-cytokeratin,
and the mesenchymal markers, vimentin, β-catenin and N-cadherin was
determinated by indirect immunofluorescence with specific antibodies. Left
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MOLECULAR CHARACTERIZATION
CONCLUSION
• We isolated two different cell line, F3II TP and F3II NM that not only differ
between themselves, they are different from the parental line F3II.
• The in vitro characterization demonstrate that the cell lines have different
doubling time, adhesion and clonogenic capacity. F3II NM presented major
adhesion capacity and lower clonogenic potential
• The three lines showed different tumoral progression in vivo. They differed in
tumor latency, tumor weight, progression and number of pulmonary nodules.
• F3II, F3II TP and F3II NM presented different epithelial-mesenchymal
phenotype. This could explain they behaviors in vivo and in vitro
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